Showing results (211-220 of 290) with videos related to
Sort By:
Pageof 29
Journal of Internal Medicine|September 22, 2022
Simple approaches to characterising multiple long-term conditions (multimorbidity) and rates of emergency hospital admission: Findings from 495,465 UK Biobank participantsRichard M Dodds, Jonathan G Bunn, Susan J Hillman, et al.American Journal of Men'S Health|May 30, 2009
Correlates of dietary intake among men involved in the MAN for Health studyGuadalupe X Ayala, India Ornelas, Scott D Rhodes, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|December 5, 2021
Outcomes from the use of computerized neurocognitive testing in a recurrent glioblastoma clinical trialK M Field, E H Barnes, H W Sim, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2005
Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumorsS N Holden, S G Eckhardt, R Basser, et al.Investigational New Drugs|March 11, 2006
Phase II study of vinflunine in patients with metastatic renal cell carcinomaD Goldstein, S P Ackland, D R Bell, et al.Appetite|March 27, 2012
Effect of the dopamine D3 receptor antagonist GSK598809 on brain responses to rewarding food images in overweight and obese binge eatersChris M Dodds, Barry O'Neill, John Beaver, et al.Addiction Biology|July 23, 2019
Value-based decision-making of cigarette and nondrug rewards in dependent and occasional cigarette smokers: An FMRI studyWill Lawn, Ludo Mithchener, Tom P Freeman, et al.Mechanisms of Ageing and Development|September 24, 2022
Immunosenescence profiles of lymphocyte compartments and multiple long-term conditions (multimorbidity) in very old adults: The Newcastle 85+ StudyAntoneta Granic, Carmen Martin-Ruiz, Lucy Rimmer, et al.American Journal of Ophthalmology|June 1, 1996
Choroidal neovascularization secondary to Candida albicans chorioretinitisL M Jampol, J Sung, J D Walker, et al.Diabetes, Obesity & Metabolism|October 6, 2015
AMG 151 (ARRY-403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetesL Katz, N Manamley, W J Snyder, et al.Pageof 29